Perspectives in Clinical Research

OPINION
Year
: 2013  |  Volume : 4  |  Issue : 4  |  Page : 196--198

Causality assessment: A casualty of compensation?


Anuradha Kulkarni, Arun Bhatt 
 Clininvent Research Pvt. Ltd, Marol Naka, Andheri (East), Mumbai, Maharashtra, India

Correspondence Address:
Arun Bhatt
Clininvent Research Pvt. Ltd., A-302, Everest Chambers, Marol Naka, Andheri - Kurla Road, Andheri (East), Mumbai - 400 059, Maharashtra
India

Recent Indian rule on compensation for any injury or death of the subject in a clinical trial, has generated a lot of discussion on its impact on clinical trials in India. The legal process in the compensation rule is based on the causality assessment. However, it ignores the scientific basis of causality assessment. This could have far reaching consequences on (1) science of causality assessment and (2) safety assessment of a new drug under clinical development. There is a need to bring clarity on causality assessment process within the compensation rules to balance the ethical need of human subject protection and the scientific requirements of safety assessment.


How to cite this article:
Kulkarni A, Bhatt A. Causality assessment: A casualty of compensation?.Perspect Clin Res 2013;4:196-198


How to cite this URL:
Kulkarni A, Bhatt A. Causality assessment: A casualty of compensation?. Perspect Clin Res [serial online] 2013 [cited 2022 Aug 19 ];4:196-198
Available from: http://www.picronline.org/article.asp?issn=2229-3485;year=2013;volume=4;issue=4;spage=196;epage=198;aulast=Kulkarni;type=0